We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Previsão é que estudo, conduzido pelo Albert Einstein, conclua uso do composto em todos os pacientes ainda nos primeiros meses de 2024; pesquisa envolverá 110 pessoas que sofrem com as dores de cabeça. Por Mariana Rosário — São Paulo [em O GLOBO] O Hospital Albert Einstein, em São Paulo, anunciou um estudo com derivado de […]
